147 related articles for article (PubMed ID: 37082061)
21. Expression of p53 as Potential Biomarker in Oral Submucous Fibrosis: An Immunohistochemical Study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
J Microsc Ultrastruct; 2023; 11(2):75-80. PubMed ID: 37448822
[TBL] [Abstract][Full Text] [Related]
22. Estimation of serum, salivary immunoglobulin G, immunoglobulin A levels and total protein, hemoglobin in smokeless tobacco chewers and oral submucous fibrosis patients.
Balakrishnan C; Aswath N
Contemp Clin Dent; 2015 Sep; 6(Suppl 1):S157-62. PubMed ID: 26604567
[TBL] [Abstract][Full Text] [Related]
23. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
24. Expression of Salivary miRNA 21 in Oral Submucous Fibrosis (OSMF): An Observational Study.
Prasad SR; Pai A; Shyamala K; Yaji A
Microrna; 2020; 9(4):295-302. PubMed ID: 31985389
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of serum and salivary total sialic acid and α-l-fucosidase in patients with oral precancerous conditions and oral cancer.
Vajaria BN; Patel KR; Begum R; Shah FD; Patel JB; Shukla SN; Patel PS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jun; 115(6):764-71. PubMed ID: 23570662
[TBL] [Abstract][Full Text] [Related]
26. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
27. Identification of EGFR as a Biomarker in Saliva and Buccal Cells from Oral Submucous Fibrosis Patients-A Baseline Study.
Moorthy A; Venugopal DC; Shyamsundar V; Madhavan Y; Ravindran S; Kuppuloganathan M; Krishnamurthy A; Sankarapandian S; Ganapathy V; Ramshankar V
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010285
[TBL] [Abstract][Full Text] [Related]
28. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
29. Proinflammatory cytokine levels in oral lichen planus, oral leukoplakia, and oral submucous fibrosis.
Kaur J; Jacobs R
J Korean Assoc Oral Maxillofac Surg; 2015 Aug; 41(4):171-5. PubMed ID: 26339574
[TBL] [Abstract][Full Text] [Related]
30. Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study.
Gosavi SR; Torkadi AA
J Oral Maxillofac Pathol; 2020; 24(1):46-51. PubMed ID: 32508447
[TBL] [Abstract][Full Text] [Related]
31. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
32. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
33. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
[TBL] [Abstract][Full Text] [Related]
35. Effect of α-tocopherol on salivary reactive oxygen species and trace elements in oral submucous fibrosis.
Chitra S; Balasubramaniam M; Hazra J
Ann Clin Biochem; 2012 May; 49(Pt 3):262-5. PubMed ID: 22337705
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.
Mohapatra D; Panda S; Mohanty N; Panda S; Lewkowicz N; Lapinska B
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511530
[TBL] [Abstract][Full Text] [Related]
37. Estimation of serum and salivary immunoglobulin G and immunoglobulin A in oral pre-cancer: A study in oral submucous fibrosis and oral lichen planus.
Divya VC; Sathasivasubramanian S
J Nat Sci Biol Med; 2014 Jan; 5(1):90-4. PubMed ID: 24678204
[TBL] [Abstract][Full Text] [Related]
38. Estimation of serum immunoglobulin G and immunoglobulin A levels in oral submucous fibrosis patients.
Swami AN; Kale LM; Choudhary SH; Singh AK; Aldhuwayhi SD; Thakare A
Natl J Maxillofac Surg; 2022; 13(1):67-71. PubMed ID: 35911796
[TBL] [Abstract][Full Text] [Related]
39. Serum alpha L-fucosidase enzyme activity in ovarian and other female genital tract tumors.
Abdel-Aleem H; Ahmed A; Sabra AM; Zakhari M; Soliman M; Hamed H
Int J Gynaecol Obstet; 1996 Dec; 55(3):273-9. PubMed ID: 9003953
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphisms and serologic levels of hypoxia-inducible factor1 α and vascular endothelial growth factor are associated with increased risk of oral submucous fibrosis in gutka users among a North Indian population.
Gupta SR; Sharma A; Gupta N; Mani K
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):557-564. PubMed ID: 32981864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
